Cash Equivalents - Hofseth Biocare ASA (OSE:HBC) - Alpha Spread

Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.705 NOK -4.21% Market Closed
Market Cap: 610.1m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hofseth Biocare ASA
Cash Equivalents Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Cash Equivalents
kr22.2m
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
36%
B
Bergenbio ASA
OSE:BGBIO
Cash Equivalents
kr117.3m
CAGR 3-Years
-44%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Cash Equivalents
kr27.4m
CAGR 3-Years
-1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash Equivalents
kr173m
CAGR 3-Years
2%
CAGR 5-Years
44%
CAGR 10-Years
23%
N
Nykode Therapeutics ASA
OSE:NYKD
Cash Equivalents
$147.3m
CAGR 3-Years
-6%
CAGR 5-Years
30%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash Equivalents
kr41.8m
CAGR 3-Years
-48%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Cash Equivalents?
Cash Equivalents
22.2m NOK

Based on the financial report for Mar 31, 2024, Hofseth Biocare ASA's Cash Equivalents amounts to 22.2m NOK.

What is Hofseth Biocare ASA's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
36%

Over the last year, the Cash Equivalents growth was -3%. The average annual Cash Equivalents growth rates for Hofseth Biocare ASA have been -46% over the past three years , -10% over the past five years , and 36% over the past ten years .

Back to Top